Clinical Trial Update: Comparison of 24-hour Holter Monitoring Versus 14-day Continuous ECG Patch Monitoring EZYPRO [NA]

View source ↗

Summary

Clinical trial update comparing 24-hour Holter monitoring versus a 14-day continuous ECG patch (EZYPRO) for detecting atrial fibrillation and other cardiac arrh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Cardiac Arrhythmia

Snippet

Sponsor: Sigknow Biomedical Co., Ltd. | Conditions: Atrial Fibrillation, Arrhythmias, Cardiac | NA | Status: UNKNOWN